loss

profile

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

$BXRX this increase has reduced my loss from 100% to 99.9%!! !

$BXRX ok,  another stop loss raid, its a bullish sign.

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

This stock has made me tons in 2021, hope to repeat this year and wipe out my other losses and plus some.

but hey: you’ve recouped some of the recent losses! Congrats!

$SAVA Guys I still see so much stock loss on SAVA Like Sammy says don’t play with scared money I am as bullish as you can be

This is how I ONLY had 2 losses in 30+ trading days.

This is how I ONLY had 2 losses in 40+ trading days.

But what made me invest and hold through the turbulence was watching Simu&#39;s safety profile &amp; performance trend further develop at each trial update--peerless and unassailable.

These clinical data combined with a clean safety profile and easy oral administration suggest highly encouraging and durable treatment effects for people living with Alzheimer’s disease.”

Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Biocryst Pharmaceuticals Inc.

trading

$XBI $BCRX XBI trading at 2017 prices holy fuck

$BCRX Jon should have been investigated for insider trading and his pulled offering and his many many misleading statements of embezzlement of riches!

Don’t fall for their bullshit, let the dogs trade with themselves

Big Loser Alert: Trading today&#39;s -8.4% move in BIOCRYST PHARMACEUTICALS $BCRX https://wp.me/p5bLGB-iCRZ

You might have lost money on every trade and every move.

but the trading, at least in my mind, seems a bit strange, and a bit like its percolating,  and something is brewing, such as 9930 prelim data, or some other pr drop is coming.

$BCRX the options pricing on this ticker trading in five cent increments really chaps my ass.

Shorting like this should be 100% illegal in my opinion and falls under manipulation of fair trading!

executive

$BCRX  
 
man ceo scamhouse sucks royal ass 
 
lying prick 
 
💩💩💩💩💩

too bad $bcrx has that chicken shit ceo scamhouse.

if anyone in $xbi $ibb are looking for a bio with a pos lying scumbag ceo then look at 
 
$BCRX 
 
one of the worst anywhere 
 
thank me later

Board needs to act as ceo has mislead his shareholders deceitful action!

Your CEO and board are lightweight morons and your shares will continue to lose value.

$BCRX “what’s the value of that” - Jack shit When You’re CEO

Your CEO and board are fucking idiots who had a solid hand

Their fucking shares are underwater because you’re a shit CEO

premium

We have no premium because Stoney is a dumb cunt.

NOW EVEN WITH NEARLY 300M IN FUCKING REVS THESE WORTHLESS FUCKS ON THE BOD CANT GET ANYTHING DONE EXCEPT SPEND TONS OF CASH ON USELESS SHIT PROGRAMS IN THE PIPE INSTEAD OF MAKING US PROFITABLE WITH WHAT THEY HAVE AN SELLING AT A PREMIUM.

but saw the .47/per - even higher premium than my $13s!

$BCRX disappointing price action over the last 3 days, the only reason why this doesn’t bother me so much is the call premium!

$BCRX Took a 50k loss, I’m the fuck outta here.

You played people here all while you lined your pocket with their losses!

$BCRX For the first time in over 2 years I might be setting a stop loss on my remaining position, dang it

$BCRX Investing in Biotech should come with a WARNING:
Will cause hair loss, vomiting, Insomnia and alcohol addiction lol

When it’s bad, it’s very bad.

That is a loss of just 18 to 19% for a VERY volatile bio market sector in a historically VERY shitty bear market.

$BCRX looks like EOY will not be very good.. 13,75 it was 31-12-2021.. now we are at 10,65.. looks like 2022 will end with a pretty big YTY loss

$BCRX this stock is as frustrating as that Spain loss 😤

Carvana swung to an adjusted operating loss of $186 million compared to a $9 million profit a year ago.

YOU MORONS HAVEN’T DONE YOUR JOB THE PAST 2 YEARS IN FORCING STONEHOUSE’S HAND FOR A BUYOUT.

Or sell the damn company and let a real Pharma with real leadership do the job.

Btw they are doing a crappy job trying to play up the new compound, cuz it’s to early.

$BCRX damn its like they knew i was gone and didn&#39;t do SHIT jobs wise

This year&#39;s star for me is ARDX which erased all my losses.

Profitability/less losses going to improve next year.

$BCRX way better investment $AUPH patent news will clear up ,sales ramping up should be a spectacular &#39;23 cut your losses here and come back to the one you

$BCRX huge move coming in $AUPH load zone around 4.67 come and regain all your losses from here 🚀🚀🚀🚀 things will get better

This is a 30.3 percent increase over losses of $(0.33) per share from the same period last year.

&quot;We believe BCX10013 has the potential to be a best-in-class treatment option with an oral, once-daily profile,”

$BCRX This is actually a good buy at these levels.

$BCRX  
European stocks rose on Friday as investors took an optimistic view of a week of data releases that showed economies in Europe and the US were more robust than expected.

#1 Suddenly alot of positive accounts appear, promoting the company has solid data, solid sales

$BCRX Have strong feeling once 10013 data is out we are going places.

$BCRX This preliminary data on BCX10013 is pretty impressive.

$BCRX great 10013 data and 320+ projected rev

but it also seems like the good choice to do so seeing iptacopan data.

Long term Bcrx should climb quarter after quarter until they align with projections billion plus!

Positive news with the early results of the new Factor D molecule 10013.

$BCRX 10% growth quarter over quarter considering flat q1 (as noted with ins payout sched) puts us at 326mil for the year.

Relative strength to SPY past 6 weeks, high growth 8 quarters straight.

$BCRX 10.5 is the new high for this first quarter.

$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.

$BCRX sales doubled 4 quarter 70.7 million + 53% year over year..

Result - volume up about 36.5% over a normal day.

But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.

Prem results in q1 and it will beat any drug in the mkt.

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Mar, 16, 2023

Dec, 28, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 11, 2023

Jan, 11, 2023

Divihomes is Now Live

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Jan, 19, 2023

Jan, 9, 2023

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Mar, 16, 2023

Dec, 28, 2022

Dec, 9, 2022

Dec, 9, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 11, 2023

Jan, 11, 2023

Dec, 30, 2022

Nov, 30, 2022

Oct, 25, 2022

Oct, 5, 2022

Oct, 2, 2022

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Jan, 19, 2023

Jan, 9, 2023

Dec, 31, 2022

Dec, 20, 2022

Dec, 15, 2022

Dec, 12, 2022

Dec, 7, 2022

Nov, 1, 2022

Nov, 1, 2022